The global prefilled syringes market is forecasted to grow from USD 8.65 billion in 2026 to USD 14.53 billion by 2031, at a CAGR of 10.9%. Key growth drivers include the rising prevalence of chronic ...
Global Prefilled Syringes Market Growth is Fueled by Increasing Demand for Biologic Drugs, Expanding Self-Administration Trends, and Advancements in Drug Delivery Technologies.Austin, United States, ...
The Food and Drug Administration (FDA) has approved new single-dose prefilled syringes for Emerphed ® (ephedrine sulfate injection) for the treatment of clinically important hypotension occurring in ...
LONG BEACH, Calif. -- Prefilled syringes to treat macular degeneration caused larger and more frequent spikes in intraocular pressure (IOP) as compared with medication drawn from vials, a study of ...
ISMP has long endorsed the use of unit dose syringes of injectable drugs, including Carpujects, as a safe practice. If Carpuject cartridges are stocked in patient care units, to ensure proper use ISMP ...
DUBLIN--(BUSINESS WIRE)--The "Prefilled Syringes - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering. The global market for Prefilled Syringes was estimated ...
MAHWAH, N.J.--(BUSINESS WIRE)-- KORU Medical Systems, Inc. (NASDAQ: KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on the development, manufacturing, and ...
Please provide your email address to receive an email when new articles are posted on . The prefilled syringe is indicated for wet age-related macular degeneration, diabetic macular edema and retinal ...
With increasing demand for efficient drug delivery systems, especially for injectable drug delivery, the need for innovative injectable drug delivery options has risen. Given the advantages of ...
Plegridy (peginterferon beta-1a) is a brand-name drug that’s prescribed for multiple sclerosis (MS) in adults. It comes in a single-use prefilled pen and prefilled syringe. Plegridy is typically given ...
BD, a leading global medical technology company, is investing more than $35 million to expand prefilled flush syringe manufacturing at its Columbus, Neb., facility. With the investment, the company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results